Author Correction | Open | Published:

Author Correction: Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials

Scientific Reportsvolume 7, Article number: 16558 (2017) | Download Citation

Subjects

Scientific Reports 7:8273; doi:10.1038/s41598-017-07921-2; Article published online 15 August 2017

The original version of this Article omitted an affiliation for Ming Zhao. The correct affiliations for Ming Zhao are listed below:

Runliang Diabetes Laboratory, Diabetes Research Center, School of Medicine, Ningbo University, 315211, Ningbo, China.

Department of Public Health, Longsai Hospital, 315200, Ningbo, China.

This has now been corrected in the HTML and PDF versions of this Article, and in the accompanying Supplemental Material.

Author information

Affiliations

  1. Runliang Diabetes Laboratory, Diabetes Research Center, School of Medicine, Ningbo University, 315211, Ningbo, China

    • Ming Zhao
    • , Jiayi Chen
    • , Yanyan Yuan
    • , Zuquan Zou
    • , Xiaolong Lai
    • , Daud M Rahmani
    • , Fuyan Wang
    • , Yang Xi
    •  & Shizhong Bu
  2. Department of Public Health, Longsai Hospital, 315200, Ningbo, China

    • Ming Zhao
  3. Department of Endocrinology, Changhai Hospital, Second Military Medical University, 200433, Shanghai, China

    • Qin Huang

Authors

  1. Search for Ming Zhao in:

  2. Search for Jiayi Chen in:

  3. Search for Yanyan Yuan in:

  4. Search for Zuquan Zou in:

  5. Search for Xiaolong Lai in:

  6. Search for Daud M Rahmani in:

  7. Search for Fuyan Wang in:

  8. Search for Yang Xi in:

  9. Search for Qin Huang in:

  10. Search for Shizhong Bu in:

Corresponding authors

Correspondence to Qin Huang or Shizhong Bu.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41598-017-16510-2

Article notes

The original article can be found online at ..https://doi.org/10.1038/s41598-017-07921-2.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.